|
AURKA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.65639995847778E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.582660E-04 |
| Normal-vs-Stage2 |
7.50919999999988E-05 |
| Normal-vs-Stage3 |
8.28930000000838E-05 |
| Normal-vs-Stage4 |
4.45869999998738E-06 |
| Stage1-vs-Stage2 |
1.963050E-01 |
| Stage1-vs-Stage3 |
3.398500E-02 |
| Stage1-vs-Stage4 |
6.027500E-04 |
| Stage2-vs-Stage3 |
2.409200E-01 |
| Stage2-vs-Stage4 |
3.923800E-03 |
| Stage3-vs-Stage4 |
4.400400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.25330001932156E-09 |
| Normal-vs-AfricanAmerican |
9.019700E-03 |
| Normal-vs-Asian |
2.138600E-01 |
| Caucasian-vs-AfricanAmerican |
9.706200E-02 |
| Caucasian-vs-Asian |
4.158400E-01 |
| AfricanAmerican-vs-Asian |
3.268800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.28199997681844E-09 |
| Normal-vs-Female |
1.50191999999105E-05 |
| Male-vs-Female |
8.818400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.043900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.43829999998957E-06 |
| Normal-vs-Age(61-80Yrs) |
1.04569999992421E-07 |
| Normal-vs-Age(81-100Yrs) |
6.803600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.671200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.614400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.693600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.944800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.786600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.686200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.437170E-01 |
| Normal-vs-Grade 2 |
3.959500E-04 |
| Normal-vs-Grade 3 |
2.7078999997876E-07 |
| Normal-vs-Grade 4 |
1.73370999999589E-05 |
| Grade 1-vs-Grade 2 |
7.497400E-03 |
| Grade 1-vs-Grade 3 |
1.6795600000008E-05 |
| Grade 1-vs-Grade 4 |
5.57869999999738E-05 |
| Grade 2-vs-Grade 3 |
6.079200E-03 |
| Grade 2-vs-Grade 4 |
3.433100E-04 |
| Grade 3-vs-Grade 4 |
5.399000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.720180E-02 |
| Normal-vs-ccB subtype |
1.20699999994756E-08 |
| ccA subtype-vs-ccB subtype |
4.20719999949526E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.72079999974473E-07 |
| Normal-vs-N1 |
1.516260E-03 |
| N0-vs-N1 |
1.379950E-02 |
|
|
